The MUC5B promoter variant results in proteomic changes in the non-fibrotic lung
Ontology highlight
ABSTRACT: The gain-of-function MUC5B promoter varaint is the dominant risk for IPF development. Herein, we performed laser capture microdissection coupled mass spectrometry to isolate the characteristic histopathological lesions of IPF, the normal-appearing alveoli/small airways, and epithelium overlying fibroblastic foci. The captured samples were subject to mass spectrometry.
INSTRUMENT(S):
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Lung, Lung Epithelium
DISEASE(S): Idiopathic Pulmonary Fibrosis
SUBMITTER:
JEREMY HERRERA
LAB HEAD: Jeremy Herrera
PROVIDER: PXD058626 | Pride | 2025-06-13
REPOSITORIES: Pride
ACCESS DATA